Abstract
Background and aims: Pain is a common post-COVID symptom which has been reported in up to 50% of coronavirus disease 2019 (COVID-19) survivors. Post-COVID pain can cause kinesiophobia, which possibly may promote and perpetuate pain. The current study investigated if post-COVID pain variables associated with the presence of kinesiophobia in a sample of previously hospitalized COVID-19 survivors.
Methods: Demographic (age, weight, height), clinical (intensity and duration of pain), psychological (anxiety/depressive level, Hospital Anxiety and Depression Scale (HADS), sleep quality (Pittsburgh Sleep Quality Index, PSQI)), cognitive (catastrophizing, the Pain Catastrophizing Scale, PCS), sensitization-associated symptoms (Central Sensitization Inventory, CSI), as well as kinesiophobia levels (11-item short-form of the Tampa Scale for Kinesiophobia, TSK-11) were collected in a cohort of 146 previously hospitalized COVID-19 survivors with post-COVID pain at 18.8 (SD+/-1.8) months after hospital discharge. Stepwise multiple linear regression models were used to identify variables associated with kinesiophobia (TKS-11) score
Results: Kinesiophobia was associated with anxiety (r: .356, P<.001), depression (r: .306, P<.001), sleep quality (r: .288, P<.001), catastrophism (r: .578, P<.001) and sensitization-associated symptoms (r: .450, P<.001). The stepwise regression analysis revealed that 38.1% of kinesiophobia variance was explained by catastrophism (r2 adj: .329, B=0.416, t=8.377, P<.001) and sensitization-associated symptoms (r2 adj: .381, B=0.130, t=3.585, P<.001).
Conclusions: This study found that kinesiophobia level was associated with catastrophism and sensitization-associated symptoms in COVID-19 survivors with post-COVID pain. Identification of patients at risk of developing higher kinesiophobia levels associated with post-COVID pain could lead to better therapeutic strategies.
Methods: Demographic (age, weight, height), clinical (intensity and duration of pain), psychological (anxiety/depressive level, Hospital Anxiety and Depression Scale (HADS), sleep quality (Pittsburgh Sleep Quality Index, PSQI)), cognitive (catastrophizing, the Pain Catastrophizing Scale, PCS), sensitization-associated symptoms (Central Sensitization Inventory, CSI), as well as kinesiophobia levels (11-item short-form of the Tampa Scale for Kinesiophobia, TSK-11) were collected in a cohort of 146 previously hospitalized COVID-19 survivors with post-COVID pain at 18.8 (SD+/-1.8) months after hospital discharge. Stepwise multiple linear regression models were used to identify variables associated with kinesiophobia (TKS-11) score
Results: Kinesiophobia was associated with anxiety (r: .356, P<.001), depression (r: .306, P<.001), sleep quality (r: .288, P<.001), catastrophism (r: .578, P<.001) and sensitization-associated symptoms (r: .450, P<.001). The stepwise regression analysis revealed that 38.1% of kinesiophobia variance was explained by catastrophism (r2 adj: .329, B=0.416, t=8.377, P<.001) and sensitization-associated symptoms (r2 adj: .381, B=0.130, t=3.585, P<.001).
Conclusions: This study found that kinesiophobia level was associated with catastrophism and sensitization-associated symptoms in COVID-19 survivors with post-COVID pain. Identification of patients at risk of developing higher kinesiophobia levels associated with post-COVID pain could lead to better therapeutic strategies.
| Originalsprog | Engelsk |
|---|---|
| Publikationsdato | sep. 2023 |
| Status | Udgivet - sep. 2023 |
| Begivenhed | 13th Congress of the European Pain Federation EFIC: Personalised Pain Management: The Future is Now - Budapest, Ungarn Varighed: 20 sep. 2023 → 22 sep. 2023 https://europeanpainfederation.eu/efic2023/ |
Konference
| Konference | 13th Congress of the European Pain Federation EFIC |
|---|---|
| Land/Område | Ungarn |
| By | Budapest |
| Periode | 20/09/2023 → 22/09/2023 |
| Internetadresse |